Renaissance Technologies’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $46.1K | Buy |
|
|||||
|
2024
Q3 | $56.8K | Buy |
|
|||||
|
2024
Q2 | $118K | Buy |
|
|||||
|
2024
Q1 | $207K | Buy |
|
|||||
|
2023
Q4 | $102K | Buy |
|
|||||
|
2023
Q3 | $154K | Buy |
|
|||||
|
2023
Q2 | $190K | Buy |
|
|||||
|
2023
Q1 | $199K | Sell |
|
|||||
|
2022
Q4 | $204K | Buy |
|
|||||
|
2022
Q3 | $409K | Buy |
|
|||||
|
2022
Q2 | $362K | Buy |
|
|||||
|
2022
Q1 | $228K | Sell |
|
|||||
|
2021
Q4 | $422K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $60K | Sell |
|
|||||
|
2019
Q2 | $187K | Buy |
|
|||||
|
2019
Q1 | $75K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $144K | Sell |
|
|||||
|
2017
Q2 | $245K | Sell |
|
|||||
|
2017
Q1 | $458K | Buy |
|
|||||
|
2016
Q4 | $400K | Buy |
|
|||||
|
2016
Q3 | $413K | Buy |
|
|||||
|
2016
Q2 | $149K | Buy |
|
|||||
|
2016
Q1 | $38K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $149K | Sell |
|
|||||
|
2014
Q1 | $153K | Buy |
|